Preventive Medicine Doctors in New Port Richey, FL Accepting Medicare

3 Preventive Medicine doctors found. Showing 1 - 3

Dr. David R Johnson, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 10841 Little Rd, New Port Richey, FL 34654 Phone: 727-861-5250    Fax: 727-862-4230

Krystal Parmar, Preventive Medicine - Undersea and Hyperbaric Medicine Medicare: Accepting Medicare Assignments Practice Location: 6804 Cecelia Drive, New Port Richey, FL 34653 Phone: 855-232-0644    Fax: 888-546-0488

Dr. Gwyn Norman Crump Jr., M.D., M.S.P.H. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 10841 Little Rd, New Port Richey, FL 34654 Phone: 727-861-5250

News Archive

Loyola plays an integral role in providing specialized training for future military physicians

Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.

UNC's bariatric surgery center receives BSCN accreditation

The program has been accredited as a Level 1b facility by the Bariatric Surgery Center Network (BSCN) Accreditation Program of the American College of Surgeons (ACS). This designation means that UNC Hospitals has met the essential criteria that ensure it is fully capable of supporting a bariatric surgery care program and that its institutional performance meets the requirements outlined by the ACS BSCN Accreditation Program.

Coronary CTA reveals different heart attack risk scenarios for men and women

Findings on coronary CT angiography (CTA), a noninvasive test to assess the coronary arteries for blockages, show different risk scenarios for men and women, according to a study presented today at the Radiological Society of North America.

FDA: Seven MDIs for treating asthma and COPD to be phased out

The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.

Read more Medical News

› Verified 5 days ago